Further trials comparing aspirin with newer anticoagulants (dabigatran, apixaban and rivaroxaban ... in the production of this manuscript. Atrial fibrillation (AF) is the most common cardiac ...
Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...
Among patients with atrial fibrillation, there is an unmet need for effective anticoagulation that prevents stroke but incurs a lower risk of bleeding than direct-acting oral anticoagulants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results